Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Modulation of Inflammation and Immunity by Cyclic AMP
1974747 citationsL.M. Lichtenstein et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by L.M. Lichtenstein
Since
Specialization
Citations
This map shows the geographic impact of L.M. Lichtenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.M. Lichtenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.M. Lichtenstein more than expected).
Fields of papers citing papers by L.M. Lichtenstein
This network shows the impact of papers produced by L.M. Lichtenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.M. Lichtenstein. The network helps show where L.M. Lichtenstein may publish in the future.
Co-authorship network of co-authors of L.M. Lichtenstein
This figure shows the co-authorship network connecting the top 25 collaborators of L.M. Lichtenstein.
A scholar is included among the top collaborators of L.M. Lichtenstein based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with L.M. Lichtenstein. L.M. Lichtenstein is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
MacGlashan, Donald W. & L.M. Lichtenstein. (1984). Dimeric IgE may not represent the unit signal for the release of all mediators in human basophils. 43(6).5 indexed citations
7.
MacGlashan, Donald W., Robert P. Schleimer, Stephen P. Peters, et al.. (1983). Comparative studies of human basophils and mast cells.. PubMed. 42(8). 2504–9.93 indexed citations
Norman, Philip S., David G. Marsh, & L.M. Lichtenstein. (1979). Long-term immunotherapy with ragweed allergen and allergoid. Journal of Allergy and Clinical Immunology. 63(3).7 indexed citations
Metre, Thomas E. Van, N. Franklin Adkinson, & L.M. Lichtenstein. (1979). Rinkel method of immunotherapy for ragweed hay fever. Journal of Allergy and Clinical Immunology. 63(3).1 indexed citations
13.
Valentine, Martin D., et al.. (1979). Regimens of hymenoptera venom immunotherapy. Journal of Allergy and Clinical Immunology. 63(3).5 indexed citations
14.
Adkinson, N. F., Harold H. Newball, Steven R. Findlay, G. K. Adams, & L.M. Lichtenstein. (1979). Origin of PGF2 alpha production following anaphylactic challenge of human lung.. PubMed. 14. 122–5.3 indexed citations
15.
Valentine, Martin D., Kevin J. Hunt, Anna Sobotka, & L.M. Lichtenstein. (1976). Venom immunotherapy for hymenoptera sensitivity: results in whole body extract (WBE) treatment failures and newly diagnosed patients. Journal of Allergy and Clinical Immunology. 57(3).2 indexed citations
Valentine, Martin D., Kevin J. Hunt, Anna Sobotka, & L.M. Lichtenstein. (1975). Therapy of vespid allergic patients with vespid venoms: Immunologic consequences. Journal of Allergy and Clinical Immunology. 55(2).1 indexed citations
18.
Lichtenstein, L.M., Anna Sobotka, Martin D. Valentine, & N. Franklin Adkinson. (1974). Treatment of honeybee anaphylactic sensitivity with honeybee venom: A case report. Journal of Allergy and Clinical Immunology. 53(2).3 indexed citations
19.
Valentine, Martin D., Anna Sobotka, & L.M. Lichtenstein. (1974). Blocking antibody to bee venom: induction by venom and not by whole body extracts. Journal of Allergy and Clinical Immunology. 53(2).5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.